Influence of insulin resistance and ribavirin dosage in viral dynamics of patients with chronic hepatitis C genotype 1 treated with peginterferon and ribavirin

被引：3
|
作者：
Grande, L.
Madrazo, A.
Viloria, M. M.
Nogales, M. C.
Corpas, R.
Camacho, I.
Sanchez-Munoz, D.
Martin-Mazuelos, E.
Romero-Gomez, M.
机构：
[1] UCM Digest Dis, Madrid, Spain
[2] Hosp Univ Valme, Microbiol Unit, Seville, Spain
[3] Hosp Univ Valme, Biochem Unit, Seville, Spain
来源：
JOURNAL OF HEPATOLOGY | 2007年 / 46卷
关键词：
D O I：
10.1016/S0168-8278(07)62236-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
638
引用
收藏
页码：S241 / S241
页数：1
相关论文
共 50 条
  • [1] Plasma ribavirin quantification in patients with chronic hepatitis C, genotype 1, treated with Peginterferon and ribavirin
    Muñoz de Rueda, Paloma
    Rodriguez, Luis
    Caudel, Jose Manuel
    Quiles, Rosa
    Andrade, Raúl
    Diago, Moises
    Navarro, Jose Maria
    HEPATOLOGY, 2006, 44 (04) : 340A - 340A
  • [2] Insulin resistance predicts rapid virological response in patients with genotype 1 chronic hepatitis C treated with peginterferon and ribavirin
    Grasso, A.
    Malfatti, F.
    Martines, H.
    De Leo, P.
    Toscanini, F.
    De Ferrari, A.
    Venturino, E.
    Anselmo, M.
    Menardo, G.
    GUT, 2008, 57 : A79 - A79
  • [3] Chronic hepatitis C genotype 1 patients with insulin resistance treated with pioglitazone and peginterferon alpha-2a plus ribavirin
    Harrison, Stephen A.
    Hamzeh, Fayez M.
    Han, Jian
    Pandya, Prashant K.
    Sheikh, Muhammed Y.
    Vierling, John M.
    HEPATOLOGY, 2012, 56 (02) : 464 - 473
  • [4] Insulin resistance, viral load and response to peginterferon and ribavirin in patients with chronic hepatitis C virus infection
    Dai, Chia-Yen
    Huang, Jee-Fu
    Hsieh, Ming-Yen
    Chuang, Wan-Long
    Yu, Ming-Lung
    GUT, 2010, 59 (03) : 418 - 418
  • [5] Early viral kinetics in patients with chronic hepatitis C genotype 2 or 3 treated with peginterferon α-2a and ribavirin
    Scherzer, Th-M.
    Staufer, K.
    Steindl-Munda, P.
    Holzmann, H.
    Ferenci, P.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S244 - S244
  • [6] Outcome of Retinopathy in Chronic Hepatitis C Patients Treated with Peginterferon and Ribavirin
    Nilesh Mehta
    Uma K. Murthy
    Vivek Kaul
    Samuel Alpert
    Gerald Abruzzese
    Charles Teitelbaum
    Digestive Diseases and Sciences, 2010, 55 : 452 - 457
  • [7] Cutaneous Reactions in Patients with Chronic Hepatitis C Treated with Peginterferon and Ribavirin
    Patrk, Ivana
    Morovic, Miro
    Markulin, Anamarija
    Patrk, Jogen
    DERMATOLOGY, 2014, 228 (01) : 42 - 46
  • [8] Outcome of Retinopathy in Chronic Hepatitis C Patients Treated with Peginterferon and Ribavirin
    Mehta, Nilesh
    Murthy, Uma K.
    Kaul, Vivek
    Alpert, Samuel
    Abruzzese, Gerald
    Teitelbaum, Charles
    DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (02) : 452 - 457
  • [9] Revisiting the Stopping Rule for Hepatitis C Genotype 1 Patients Treated with Peginterferon Plus Ribavirin
    Yu, Ming-Lung
    Liu, Chen-Hua
    Huang, Chung-Feng
    Tseng, Tai-Chung
    Huang, Jee-Fu
    Dai, Chia-Yen
    Lin, Zu-Yau
    Chen, Shinn-Cherng
    Wang, Liang-Yen
    Juo, Suh-Hang Hank
    Chuang, Wan-Long
    Kao, Jia-Horng
    PLOS ONE, 2012, 7 (12):
  • [10] Peginterferon and ribavirin for chronic hepatitis C
    Hoofnagle, Jay H.
    Seeff, Leonard B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (23): : 2444 - 2451
12345